drugset / Trial / NCT01952535

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

NCT01952535

Phase 1 Completed 60 enrolled Hua Medicine Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study is to determine the safety profiles, tolerability, pharmacokinetics and pharmacodynamics of HMS5552 following single ascending doses in healthy adult subjects.

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzagliatin Small molecule Oral